pharmaphorum13d
Bad news for Pfizer as blockbuster Xeljanz flunks safety study
JAK inhibitor Xeljanz is one of Pfizer’s top-selling drugs, despite a ‘black box’ warning for blood clots and cancers added to its label in 2019. Now, a study designed to prove its safety ...
pharmaphorum12d
Pfizer’s rheumatoid arthritis drug is approved by the FDA
Pfizer has received approval from the US FDA for its rheumatoid arthritis (RA) drug, Xeljanz, which is the first approved RA treatment in a new class of medicines known as Janus kinase inhibitors ...
Pfizer's Direct-To-Consumer Model Faces Scrutiny From US Senators (UPDATED)
This article has been updated to include a statement from UpScriptHealth. In August 2024, Pfizer Inc (NYSE:PFE) introduced ...
Business Insider5y
Drugmakers from Pfizer to GSK to hike US prices on over 200 drugs, as prescription drug prices become a hot 2020 campaign topic
and rheumatoid arthritis drug Xeljanz. Pfizer spokeswoman Amy Rose confirmed the company's planned price increases. She said the company plans to increase the list prices on around 27% of its ...